SONOMA PHARMACEUTICALS, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $4.65 million for the 3-month period ending 2017-12-31, per its 10-Q filed 2018-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-02-14
- SONOMA PHARMACEUTICALS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $4.65M, a 46.41% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $4.14M, a 60.99% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $3.60M, a 49.44% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $3.80M, a 60.36% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $11.96M, a 48.04% increase from fiscal 2016.
- SONOMA PHARMACEUTICALS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $8.08M, a 18.73% decline from fiscal 2015.
- SONOMA PHARMACEUTICALS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $9.94M, a 37.85% increase from fiscal 2014.
- SONOMA PHARMACEUTICALS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $7.21M, a 44.10% decline from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $4.65M 10-Q · filed 2018-02-14 | $8.79M derived: sum of 2 quarters · filed 2018-02-14 | $12.39M 10-Q · filed 2018-02-14 | $16.19M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2017-09-30 | $4.14M 10-Q · filed 2017-11-14 | $7.75M 10-Q · filed 2017-11-14 | $11.55M derived: sum of 3 quarters · filed 2017-11-14 | $14.72M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2017-06-30 | $3.60M 10-Q · filed 2017-08-08 | $7.40M derived: sum of 2 quarters · filed 2017-08-08 | $10.58M derived: sum of 3 quarters · filed 2018-02-14 | $13.15M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2017-03-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | $6.97M derived: sum of 2 quarters · filed 2018-02-14 | $9.55M derived: sum of 3 quarters · filed 2018-02-14 | $11.96M 10-K · filed 2017-06-28 | ||||
| 2016-12-31 | $3.17M 10-Q · filed 2018-02-14 | $5.75M derived: sum of 2 quarters · filed 2018-02-14 | $8.16M 10-Q · filed 2018-02-14 | $10.53M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-09-30 | $2.57M 10-Q · filed 2017-11-14 | $3.81M 10-Q · filed 2016-11-15 | $4.99M 10-Q · filed 2017-11-14 | $7.32M 10-Q · filed 2016-11-15 | $7.35M derived: sum of 3 quarters · filed 2017-11-14 | $9.57M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $2.41M 10-Q · filed 2017-08-08 | $3.51M 10-Q · filed 2016-08-09 | $4.78M derived: sum of 2 quarters · filed 2017-08-08 | $6.99M derived: sum of 3 quarters · filed 2017-08-08 | $10.40M derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-03-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | $4.58M derived: sum of 2 quarters · filed 2017-06-28 | $7.99M derived: sum of 3 quarters · filed 2017-06-28 | $8.08M 10-K · filed 2017-06-28 | $13.04M 10-K · filed 2016-06-21 | |||
| 2015-12-31 | $2.21M 10-Q · filed 2017-02-17 | $3.47M 10-Q · filed 2016-02-16 | $5.62M derived: sum of 2 quarters · filed 2017-02-17 | $5.71M 10-Q · filed 2017-02-17 | $9.79M 10-Q · filed 2016-02-16 | $11.80M derived: sum of 4 quarters · filed 2017-02-17 | ||
| 2015-09-30 | $3.40M 10-Q · filed 2016-11-15 | $6.32M 10-Q · filed 2016-11-15 | $9.59M derived: sum of 3 quarters · filed 2016-11-15 | $12.06M derived: sum of 4 quarters · filed 2016-11-15 | ||||
| 2015-06-30 | $2.92M 10-Q · filed 2016-08-09 | $6.18M derived: sum of 2 quarters · filed 2016-08-09 | $8.66M derived: sum of 3 quarters · filed 2016-08-09 | $10.73M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-21 | $5.74M derived: sum of 2 quarters · filed 2016-06-21 | $7.82M derived: sum of 3 quarters · filed 2016-06-21 | $9.94M 10-K · filed 2016-06-21 | ||||
| 2014-12-31 | $2.47M 10-Q · filed 2016-02-16 | $2.65M 10-Q · filed 2015-02-12 | $4.55M derived: sum of 2 quarters · filed 2016-02-16 | $6.67M 10-Q · filed 2016-02-16 | $8.14M 10-Q · filed 2015-02-12 | $5.25M derived: sum of 4 quarters · filed 2016-02-16 | ||
| 2014-09-30 | $2.08M 10-Q · filed 2015-11-10 | $2.69M 10-Q · filed 2014-11-13 | $4.20M 10-Q · filed 2015-11-10 | $5.49M 10-Q · filed 2014-11-13 | $2.78M derived: sum of 3 quarters · filed 2015-11-10 | $5.23M derived: sum of 4 quarters · filed 2015-11-10 | ||
| 2014-06-30 | $2.12M 10-Q · filed 2015-08-07 | $2.79M 10-Q · filed 2014-08-12 | $704.00K derived: sum of 2 quarters · filed 2015-08-07 | $3.15M derived: sum of 3 quarters · filed 2015-08-07 | $6.61M derived: sum of 4 quarters · filed 2015-08-07 | |||
| 2014-03-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-16 | $1.03M derived: sum of 2 quarters · filed 2015-06-16 | $4.49M derived: sum of 3 quarters · filed 2015-06-16 | $7.21M 10-K · filed 2015-06-16 | $10.89M 10-K · filed 2014-06-30 | |||
| 2013-12-31 | $2.45M 10-Q · filed 2015-02-12 | $5.91M derived: sum of 2 quarters · filed 2015-02-12 | $8.63M 10-Q · filed 2015-02-12 | $11.21M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-09-30 | $3.46M 10-Q · filed 2014-11-13 | $6.18M 10-Q · filed 2014-11-13 | $8.76M derived: sum of 3 quarters · filed 2014-11-13 | $11.42M derived: sum of 4 quarters · filed 2014-11-13 | ||||
| 2013-06-30 | $2.72M 10-Q · filed 2014-08-12 | $5.31M derived: sum of 2 quarters · filed 2014-08-12 | $7.96M derived: sum of 3 quarters · filed 2014-08-12 | $11.85M derived: sum of 4 quarters · filed 2014-08-12 | ||||
| 2013-03-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | $5.24M derived: sum of 2 quarters · filed 2014-06-30 | $9.13M derived: sum of 3 quarters · filed 2014-06-30 | $12.90M 10-K · filed 2014-06-30 | ||||
| 2012-12-31 | $2.65M 10-Q · filed 2014-02-14 | $6.54M derived: sum of 2 quarters · filed 2014-02-14 | $10.31M 10-Q · filed 2014-02-14 | $13.46M derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2012-09-30 | $3.89M 10-Q · filed 2013-11-19 | $7.67M 10-Q · filed 2013-11-19 | $10.81M derived: sum of 3 quarters · filed 2013-11-19 | $13.31M derived: sum of 4 quarters · filed 2013-11-19 | ||||
| 2012-06-30 | $3.80M 10-Q · filed 2013-08-14 | $3.82M 10-Q/A · filed 2012-08-31 | $6.92M derived: sum of 2 quarters · filed 2013-08-14 | $9.42M derived: sum of 3 quarters · filed 2013-08-14 | $12.72M derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-03-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $5.62M derived: sum of 2 quarters · filed 2013-06-25 | $8.91M derived: sum of 3 quarters · filed 2013-06-25 | $11.49M 10-K · filed 2013-06-25 | $11.85M 10-K · filed 2012-06-21 | |||
| 2011-12-31 | $2.50M 10-Q · filed 2013-02-13 | $2.60M 10-Q · filed 2012-02-10 | $5.80M derived: sum of 2 quarters · filed 2013-02-13 | $8.38M 10-Q · filed 2013-02-13 | $8.70M 10-Q · filed 2012-02-10 | $11.01M derived: sum of 4 quarters · filed 2013-02-13 | ||
| 2011-09-30 | $3.30M 10-Q · filed 2012-11-08 | $3.39M 10-Q · filed 2011-11-03 | $5.91M 10-Q · filed 2012-11-08 | $6.10M 10-Q · filed 2011-11-03 | $8.50M derived: sum of 3 quarters · filed 2012-11-08 | $10.51M derived: sum of 4 quarters · filed 2012-11-08 | ||
| 2011-06-30 | $2.71M 10-Q/A · filed 2012-08-31 | $5.21M derived: sum of 2 quarters · filed 2012-08-31 | $7.21M derived: sum of 3 quarters · filed 2012-08-31 | $9.49M derived: sum of 4 quarters · filed 2012-08-31 | ||||
| 2011-03-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-21 | $4.50M derived: sum of 2 quarters · filed 2012-06-21 | $6.78M derived: sum of 3 quarters · filed 2012-06-21 | $8.83M 10-K · filed 2012-06-21 | ||||
| 2010-12-31 | $2.00M 10-Q · filed 2012-02-10 | $4.29M derived: sum of 2 quarters · filed 2012-02-10 | $6.33M 10-Q · filed 2012-02-10 | |||||
| 2010-09-30 | $2.28M 10-Q · filed 2011-11-03 | $4.33M 10-Q · filed 2011-11-03 | ||||||
| 2010-06-30 | $2.04M 10-Q/A · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |